Introduction {#s1}
============

The vast nutritional benefits of a diet containing a wide variety of plants have long been known. However, benefits distinct from simple nutrition, such as phytochemicals have recently become clear. Diets rich in a plethora of phytochemicals can promote a healthy and diverse gut microbiota, reduce intestinal and systemic inflammation, and decrease the risk of colorectal cancer and type 2 diabetes mellitus.

Some of these benefits can be observed around the world. Many parts of India have historically low colon cancer incidence rates \[[@R1]\]. The Indian subcontinent has been continuously settled for millennia. Ancient cities in the Indus valley have been dated to the third and fourth millennia BC and some sites are even older. Archaeological evidence of grain cultivation, including several varieties of barley and wheat, has been found in excavations dated to the sixth millennium BC. Wheat is still a staple crop in northern India, and many other grains, including barley, were commonly cultivated and eaten until the 1950s, when wheat and white rice became dominant \[[@R2]\]. Although the country has many diverse cultures, some customs remain common and conventional throughout the nation. One such tradition is the form of main meals where a large round platter, the *thali*, holds rice or bread and several smaller bowls, or *katori*, which hold a separate condiment or curry to be eaten with the rice or bread at the diner's preference \[[@R3],[@R4]\]. Typical dishes include, but are not limited to, *dal* (legumes; prebiotics), yogurt (probiotics), and assorted spices and vegetables (provides fiber and different classes of phytochemicals) \[[@R3]\].

The development of agriculture early in its history has allowed India to develop rich traditions around food. These traditions have been deeply influenced by Ayurveda, the ancient Indian system of medicine. In Ayurvedic practice, food is a source of nourishment and medicine, used to both prevent and treat illness. Maintaining a proper balance of Ayurvedic elements through diet is considered an effective way to live a healthy lifestyle.

According to the Ayurvedic principles, each meal should contain a balance of the six major flavors (sweet, salty, sour, bitter, pungent, and astringent) \[[@R5]\]. This calls for the many small portions of a *thali* meal which also easily incorporate variety \[[@R6]\]. A variety of flavors in a meal often indicates the presence of many classes of bioactive compounds ([Figure 1](#F1){ref-type="fig"}). Although these substances may not be macronutrients, vitamins, or minerals, they still impact human health. Polyphenols are perhaps the largest class of bioactive compounds, containing subclasses such as flavonoids, isoflavones, stilbenes, lignans, and tannins. As a flavonoid subgroup, anthocyanins are included in this class.

Anthocyanins are of interest in the food industry as nontoxic and water-soluble pigments, as most are colored red, purple, or blue, and many display antioxidant and anti-inflammatory activity \[[@R6]\]. A class of phytochemicals called polyphenols is also found in virtually all plant foods, though their quantity may be reduced by preparation methods. Rich sources of anthocyanins include deeply colored fruits and vegetables, such as blueberries, eggplants, and certain carrot and potato cultivars \[[@R6]-[@R8]\]. Given that many phytochemicals exert anti-inflammatory activity via promoting gut bacterial diversity, there is a growing interest in a food-based approach to countering the growing epidemic of inflammation-promoted chronic diseases such as colon cancer.

Promoting Gut Bacterial Diversity Using *Thali* Diet Approach {#s2}
=============================================================

We have learned that no discussion of diet is complete without consideration of the intestinal microbiota. Trillions of bacteria, distributed throughout the gastrointestinal tract from mouth to anus, facilitate digestion and intestinal homeostasis \[[@R9]\]. Structural factors greatly impact the overall makeup of each community. For example, low pH prohibits many pathogenic bacteria from colonizing the stomach and the upper small intestine. The depths of the large intestine, on the other hand, is an ideal habitat for many anaerobes. The gut microbiota is a dynamic community, composed of living organisms that can alter in response to diet, disease, and other environmental pressures \[[@R10]\].

Changes in the intestinal microbiota were first correlated with illness in 1681 when Anton van Leeuwenhoek recorded that the microbial composition of his diarrhea differed from normal fecal samples \[[@R11]\]. Since then, the intestinal microbiome has been closely studied to show how it can be implicated in a variety of conditions ranging from obesity to colon cancer. A great deal of investigation into microbiota has been accomplished in the last decade. Many of these observed changes result in an overall loss of bacterial diversity in the microbiota, indicating that species diversity is associated with health \[[@R11]-[@R13]\]. However, the opposite may be true for cause-consequence relations, but not enough research has been brought to light.

High-throughput technologies have driven advances in identifying the trillions of microbes and the metabolic functions that live in the colon. This led to a critical insight that gut plays as dynamic of a role in metabolism as the liver. The proximity of these microbes to the intestinal mucosa and gut lymphoid tissue explains the critical role they play in health and disease. Indeed, dysbiosis plays a significant role in the development of inflammatory bowel disease, obesity, and colon cancer. Emerging evidence suggests that diet can directly influence the content and composition of gut microbiota. Thus, understanding the complex interactions between diet, gut microbiota, and the host are crucial in prevention and treatment of chronic diseases that plague our society \[[@R14]\]. Studies in murine models have shown rapid changes in the gut bacteria of mice being switched quickly from a standard diet to a high-calorie diet back to a standard diet \[[@R14]\]. In humans, surveys show that diets high in fiber correlate with higher microbial diversity and reduced populations of *Enterobacteriaceae*, including *Escherichia* and *Shigella* species \[[@R15]\]. Marked differences are also seen during consumption of animal- vs. plant-based diets \[[@R10]\].

While nutrients in the diet will affect intestinal microbes, other substances present in food may also have an effect. For example, most anthocyanins are not absorbed into the bloodstream in the small intestine, and so they stay in the gastrointestinal tract until they reach the colon \[[@R16]\]. There, they can affect the colonic microbiota in multiple ways. Firstly, anthocyanins have antioxidant activity that can reduce inflammation-induced oxidative stress on the gut bacteria \[[@R17]\]. Secondly, anthocyanins are a potential carbon source, which bacteria can metabolize, resulting in increased growth of certain microbes \[[@R7]\]. Lastly, bacterial metabolism of anthocyanins produces a variety of metabolite byproducts, some of which have antimicrobial effects on enteric pathogen species including *Escherichia coli* \[[@R16]\]. 

*Thali* Diet Approach to Countering Inflammation-Promoted Chronic Diseases {#s3}
==========================================================================

Chronic intestinal inflammation is a hallmark of certain bowel disorders, such as ulcerative colitis and Crohn's disease, which are two major forms of inflammatory bowel diseases (IBD), and IBD is also considered a risk factor for colorectal cancer. In the latter, inflammation is generally low-grade but persists over a long period of time. Diet composition can promote or suppress chronic inflammation. Low-fiber high-calorie diets, which are typical in Western countries, may directly promote inflammation, or as already discussed, indirectly promote this through dysbiosis. Indeed, some dietary patterns associated with chronic inflammation are also linked to the reduction of total microbial diversity and imbalances in intestinal microbial groups \[[@R10],[@R18]\]. Furthermore, some bacteria, including *E. coli*, can flourish during low-grade inflammation, where thinning of the intestinal mucus layer occurs and allows for more direct interaction between the host's cells and the intestinal bacteria. This condition can cause a feedback loop in which contact between bacteria and epithelial cells leads to dysregulation of mucosal immune response. This contact can lead to a bacterial biofilm, formed when bacteria attach themselves to the surfaces of the aqueous environment in the gut and begin to secrete substances that allow them to affix onto the epithelium. The interaction between bacteria and epithelial cells elevates inflammation, leading to increased thinning of the mucus and direct host-bacteria interaction. The *thali* approach, however, combats this cycle in two different ways: by suppressing bacterial growth with anti-microbial phytochemicals (for example, curcumin), and by reducing the opportunity for inflammation to occur.

One molecular pathway involved in such a cycle involves interleukin 6 (IL6). This cytokine is normally expressed during acute inflammatory responses, and among other effects, upregulates the transcription factor STAT3. In the nucleus, STAT3 promotes cell proliferation and differentiation as well as upregulating anti-apoptosis genes. When IL6 is chronically elevated, it can lead to an apoptosis-resistant, constantly expanding T-cell population in the intestinal mucosa. These cells can further contribute to chronic inflammation \[[@R19]\].

Just as a certain diet may promote chronic inflammation, a change in diet can help to restore health. Various bioactive compounds, including anthocyanins, have demonstrated antioxidant activity, reducing local amounts of reactive oxygen species. Low levels of reactive oxygen species can lower the expression of some inflammatory genes, including IL6, and relieve the stresses on both the intestinal microbiota and epithelial cells caused by chronic inflammation \[[@R20],[@R21]\]. In a study of pigs, we found that supplementing (10 percent w/w) a high-calorie diet (HCD) with purple potatoes that contains anthocyanins led to a six-fold reduction in levels of interleukin-6 (IL6) compared to high-fat diet control \[[@R22]\].

Colorectal cancer (CRC) killed nearly 774,000 people worldwide in 2015, and nearly an estimated 50,630 deaths in 2018 in America making it the third leading cause of cancer-related deaths in the United States in women and second in men \[[@R23],[@R24]\]. Virtually all cases of CRC are considered to result from an interplay of exogenous and endogenous factors with respect to the variable contribution from each factor \[[@R25],[@R26]\]. Some non-modifiable risk factors include old age and family history of CRC. Other risk factors, however, are associated with lifestyle or behaviors and thus can be changed.

These modifiable risk factors include smoking, obesity, low physical activity, deficiency of dietary fiber, deficiency of vitamin D, deficiency of folate, high intake of red and processed meat, and alcohol consumption \[[@R26]-[@R28]\].

Some of these risk factors, however, are closely related. For example, inadequate fiber intake and excessive fat intake are dietary risk factors which tend to lead to a lack of exercise which ultimately may contribute to obesity, particularly in combination. In the US, 40 percent of adults are obese, and so the risk factors discussed are common mainly due to the modern Western lifestyle. Therefore, it is no surprise that nearly half of the CRC cases arise in the developed nations.

The Western diet in its current form contains more risk factors than the calorie and fat content. Foods that contain heterocyclic amines (HCA), polycyclic aromatic hydrocarbons (PAH), and emulsifiers can also contribute to carcinogenesis. HCA and PAH are produced in meats when they are fried or grilled over an open flame. These substances have been proved to damage the DNA of colonocytes and potentially promote risk of colon cancer \[[@R29]\]. Emulsifiers are used in foods like ice cream to ensure an even distribution of fat molecules. Recent evidence suggests, however, that emulsifiers promote intestinal inflammation, creating an environment that favors colon carcinogenesis in mice \[[@R30]\]. Some of these risk factors, however, are closely related. For example, inadequate fiber intake and excessive fat intake are dietary risk factors. These tend to lead to a lack of exercise, which ultimately contributes to obesity. In the US, 40 percent of adults are obese, and so the risk factors discussed are common mainly due to the modern Western lifestyle. Therefore, it is no surprise that nearly half of CRC cases arise in developed nations. However, colon cancer has a long development period (10 to 30 years). This gives ample time for lifestyle changes to take place, including diet-based intervention.

Chronic inflammation, a condition that is promoted by dietary risk factors also contributes to the development of cancer, even in humans. Patients with inflammatory bowel disease have a significantly increased risk of developing CRC, while long-term aspirin treatment is associated with a significantly decreased risk of CRC \[[@R31]\]. The mechanisms by which chronic inflammation promotes tumor development often involve the immune system. For example, the IL6/STAT pathway discussed earlier is also implicated in cancer formation. Overexpression of IL6 leads to excess STAT3 transcription, causing unwanted cell proliferation not only in T cells but also in the intestinal epithelium \[[@R20],[@R30],[@R31]\]. Another inflammatory cytokine of note is TNF α (tumor necrosis factor α) \[[@R32]-[@R34]\].

While the intestinal bacteria can promote inflammation, they may also affect the likelihood of CRC more directly. Once the intestinal mucus layer is thinned, and direct bacterial-epithelial cell interactions occur, certain bacterial strains promote tumor development. *E. coli* strains bearing the *pks* island are of particular interest. This genetic locus codes for the secondary metabolite colibactin, along with the enzymes necessary for its production \[[@R35]\]. Colibactin has been shown to crosslink with DNA, producing double-stranded breaks \[[@R36]\]. Furthermore, *pks*+ *E. coli* strains have been shown to be prevalent in CRC patients. In one study, nearly two-thirds of CRC patients had *pks*+ *E. coli* strains in their intestinal bacteria. In the same study, *pks*+ *E. coli* also existed in about 20 percent of healthy individuals \[[@R32]\]. Colibactin, however, is a reactive and short-lived protein, requiring close contact with epithelial cells to cause DNA damage \[[@R32]\]. A healthy mucosal barrier (one not thinned by chronic inflammation) keeps colibactin at a distance and reduces the chance of affecting the intestinal epithelium.

Evidence for the pathogenic relationship between diets, *Fusobacterium nucleatum*, and CRC has been emerging \[[@R37],[@R38]\]. The *F. nucleatum*levels have been shown to be higher in CRC than in adjacent normal mucosa \[[@R39]\]. Utilizing the molecular pathological epidemiology paradigm and methods \[[@R25],[@R40]\], a recent study has shown the association of fiber-rich diets (so-called prudent dietary pattern) with decreased risk of *F. nucleatum*-detectable CRC, but not that of *F. nucleatum*-undetectable CRC \[[@R41]\]. Experimental evidence supports a carcinogenic role of*F. nucleatum* \[[@R42]-[@R45]\],as well as its role in modifying therapeutic outcomes \[[@R46]\]. The amount of*F. nucleatum*in CRC tissue has been associated with proximal tumor location, CpG island methylator phenotype (CIMP), microsatellite instability (MSI) \[[@R47],[@R48]\], low-level CD3+ T cell infiltrate \[[@R49]\], high-level macrophage infiltration \[[@R50]\], and unfavorable patient survival \[[@R47],[@R48]\]. The amount of*F. nucleatum* in average increased in CRC from rectum to cecum \[[@R51]\], supporting the colorectal continuum model \[[@R52],[@R53]\]. Future studies should examine the role of diets, microbiota, and CRC in detailed tumor locations.

Dietary prevention of CRC, then, has two intertwined aims: to reduce inflammation and to promote a healthy intestinal microbiota. As already discussed, preclinical evidence implies that dietary bioactive compounds, particularly anthocyanins, can reduce symptoms of low-grade chronic inflammation as well as oxidative stress. It can also aid in balancing the intestinal microbiota by promoting the growth of beneficial bacteria and by reducing the populations of pro-inflammatory bacteria \[[@R8],[@R20]\]. Clinical trials have had mixed results, but anthocyanins and some polyphenols have shown to counteract against CRC actively. More research, however, is necessary for conclusive results \[[@R54]\].

How, then, are individuals to consume enough bioactive compounds to have an effect on health? Some answers may be found in the food consumption practices of cultures with historically low CRC incidence. Parts of India, for example, have had some of the lowest CRC incidence rates in the world \[[@R1]\]; however, this status has been changing.

In recent decades, increasing urbanization and similar factors have led to progressively Westernized diet patterns and lifestyle \[[@R55]\]. CRC incidence rates are similarly rising, lending weight to the hypothesis that the traditional Indian diet may help prevent CRC \[[@R56]\]. Furthermore, Indian immigrants to Western countries have a much higher incidence of CRC \[[@R57]\] compared to Indians in India. Typical components of traditional Indian meals include a broad variety of flavors, as promoted in Ayurvedic medicine, and a variety of other foods. Both are facilitated by using a *thali* platter to serve the meal \[[@R3],[@R4]\]. The traditional American main meal includes an entree (the main source of protein, usually containing meat or fish), one or more carbohydrates (potatoes, rice, pasta, bread, etc.), and one or more vegetables \[[@R5]\]. This basic structure can potentially be adapted with inspiration from *thali* meals by reducing the size of the main dish and serving more vegetables, legumes, pulses, herbs, and spices to accompany it.

A unique component to *thali* is the combination of many tastes and colors. The inclusion of multiple colors in a meal is desirable, because certain bioactive compounds, particularly anthocyanins are also pigments. Blue, purple, and red-purple colors in plant foods indicate high anthocyanin content. Purple-pigmented potatoes can be prepared in the same way as traditional white potatoes, but the anthocyanin content is significantly higher in the pigmented varieties \[[@R6]\]. Purple sweet potatoes also contain more anthocyanins than the more common orange varieties and can be easily substituted for them \[[@R58]\]. Other vegetables with red or purple cultivars include carrots, cauliflower, and cabbage \[[@R17]\]. Different colors can indicate the presence of other bioactive compounds, such as orange (carotenes), yellow (lutein and zeaxanthin), and red/pink (lycopene). Thus, healthy bioactive compound consumption may be increased by selecting colorful vegetables. Another way to increase consumption of bioactive compounds is to increase their presence in available foods. The content of bioactive compounds in plant foods is highly influenced by genetics \[[@R59]-[@R61]\]. The agricultural industry could greatly impact health by adopting food plant cultivars that produce bioactive compounds in larger amounts than is currently common. New cultivars may need to be developed that retain desirable characteristics such as large size, pest resistance, reduced spoilage, etc., but also have high bioactive content at the time of consumption. Bioactive compounds, with some exceptions, tend to deteriorate during storage \[[@R62]-[@R64]\]. Even when compounds have not deteriorated, storage may reduce the anti-inflammatory/antioxidant activity of bioactive compounds to affect health \[[@R65]\]. A second systemic change that would promote increased bioactive compound consumption involves reworking how fruits and vegetables are currently stored and processed, as well as reducing the average storage time and adapting processing to optimize the amount of bioactive compounds. Presently, "nutritional adequacy" does not consider many of the bioactive compounds discussed in this paper. Further clinical studies are needed to support and elucidate the role of bioactive compounds in the prevention and treatment of disease.

Conclusion {#s4}
==========

Recent research provides preclinical evidence that phytochemicals, especially anthocyanins, promote gut microbial health, reduce inflammation, and lower the risk of colorectal cancer. Clinical evidence is sparse but indicates that anthocyanins and other bioactive compounds do have an effect on colon cancer \[[@R54]\]. Both are consistent with low cancer rates in India, where both traditional diet and Ayurvedic medicine promote consumption of many classes of phytochemicals. Long-term, diet-based randomized clinical trials are both difficult to conduct and prohibitively expensive. However, given the strong evidence from basic studies, observational data, and randomized clinical studies with short-term surrogate outcomes, steps should still be taken to improve the consumption of bioactive compounds, particularly in countries which contain a large proportion of CRC patients \[[@R55]\]. Eating a wide variety of plant foods has no ill effects, and is indeed a commonly recommended part of a healthy lifestyle \[[@R55]\]. Increasing bioactive intake among Westerners will require modifications in both individual eating habits and food system practices \[[@R66]\].
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![The *thali* diet promotes gut bacterial diversity by delivering probiotics, prebiotics, and different classes of phytochemicals from fermented foods, *dal* and vegetables and spices, respectively. Indeed, *sambar*, a component of the*thali* diet suppressed chemically-induced colon carcinogenesis *in vivo* \[[@R67]\]. \*Black and white peppercorns, cloves, cinnamon, mace (part of nutmeg), black and green cardamom pods, bay leaf, cumin, and coriander.](yjbm_91_2_177_g01){#F1}
